Back to Trades
Milligan Sandra
DirectorCIK 0001859810
Profile
- Filings
- 4
- Buy transactions
- 1
- Sell transactions
- 0
- Companies
- 2
- Active
- 2025–2026
Milligan Sandra, Director, has filed 4 SEC reports (2025–2026), spread across 2 companies, totaling $762.4K in disclosed volume. Weighing $50.0K bought versus $0 sold, the history is heavily weighted toward buying. The largest single open-market purchase on record is $50.0K in Gossamer Bio, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Sep 25 | GOSS Gossamer Bio, Inc. | Milligan Sandra | Director | Award | $109.9K |
| Jun 5 | GOSS Gossamer Bio, Inc. | Milligan Sandra | Director | Award | $20.5K |
| May 29 | SYRE Spyre Therapeutics, Inc. | Milligan Sandra | Director | Award | $582.0K |
| Aug 20 | GOSS Gossamer Bio, Inc. | Milligan Sandra | Director | Buy | $50.0K |
4 filings